Literature DB >> 3546594

Incubation periods and survival times for mice injected stereotaxically with three scrapie strains in different brain regions.

Y S Kim, R I Carp, S M Callahan, H M Wisniewski.   

Abstract

Incubation period and survival time were determined in C57BL mice which had been injected stereotaxically with either the 139A, ME7 or 22L strain of scrapie in one of five different brain regions (cerebral cortex, caudate nucleus, thalamus, substantia nigra, cerebellum). The injection of 139A in the caudate nucleus, thalamus, substantia nigra or cerebellum resulted in significantly shorter incubation periods than following cerebral cortex injection. For ME7, mice injected in the thalamus and cerebellum had incubation periods approximately 2 weeks shorter than the cerebral cortex group. For 22L, the incubation periods after substantia nigra or cerebellum injection were significantly shorter than after cortex injection. The cerebellum injection group had a significantly shorter incubation period than the substantia nigra injection group. The survival times for mice injected with a particular scrapie strain were directly related to the incubation periods. The groups with the shortest incubation also had the shortest survival time (e.g. 22L in the cerebellum). On histological examination, 139A and ME7 produced brain lesions in all brain areas regardless of injection site. For the 22L strain, after cerebellum injection vacuolation was limited to the cerebellum, while injection into the cerebral cortex and other forebrain regions resulted in vacuolation in all brain regions examined. Despite the difference in the distribution of vacuolation seen in cerebellum- compared to cortex-injected (22L) mice, infectivity titres were similar in the cortex, cerebellum, cerebellar cortex and medulla plus pons.

Entities:  

Mesh:

Year:  1987        PMID: 3546594     DOI: 10.1099/0022-1317-68-3-695

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes.

Authors:  J F Diedrich; H Minnigan; R I Carp; J N Whitaker; R Race; W Frey; A T Haase
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  A rapid accurate culture assay for infectivity in Transmissible Encephalopathies.

Authors:  Ying Liu; Ru Sun; Trisha Chakrabarty; Laura Manuelidis
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

3.  Remarkable Activation of the Complement System and Aberrant Neuronal Localization of the Membrane Attack Complex in the Brain Tissues of Scrapie-Infected Rodents.

Authors:  Yan Lv; Cao Chen; Bao-Yun Zhang; Kang Xiao; Jing Wang; Li-Na Chen; Jing Sun; Chen Gao; Qi Shi; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2014-10-14       Impact factor: 5.590

4.  Incubation periods and histopathological changes in mice injected stereotaxically in different brain areas with the 87V scrapie strain.

Authors:  Y S Kim; R I Carp; S Callahan; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Interaction of scrapie agent and cells of the lymphoreticular system.

Authors:  R I Carp; S M Callahan; B A Patrick; P D Mehta
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Authors:  Samia Hannaoui; Layal Maatouk; Nicolas Privat; Etienne Levavasseur; Baptiste A Faucheux; Stéphane Haïk
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

7.  A morphometric and immunohistochemical study of the vestibular nuclear complex in bovine spongiform encephalopathy.

Authors:  M Jeffrey; W G Halliday; C M Goodsir
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Brain region specific pre-synaptic and post-synaptic degeneration are early components of neuropathology in prion disease.

Authors:  Zuzana Šišková; Richard A Reynolds; Vincent O'Connor; V Hugh Perry
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

9.  Effective gene therapy in a mouse model of prion diseases.

Authors:  Karine Toupet; Valérie Compan; Carole Crozet; Chantal Mourton-Gilles; Nadine Mestre-Francés; Françoise Ibos; Pierre Corbeau; Jean-Michel Verdier; Véronique Perrier
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

10.  T-Tau and P-Tau in Brain and Blood from Natural and Experimental Prion Diseases.

Authors:  Richard Rubenstein; Binggong Chang; Robert Petersen; Allen Chiu; Peter Davies
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.